Effects of Somatostatin-14 and -8 on Portal Hemodynamics in Patients with Portal Hypertension after Intrahepatic Portosystemic Shunt

YANG Jian-fen,WU Xing-jiang,LI Jie-shou,CAO Jian-min,HAN Jian-ming
DOI: https://doi.org/10.3969/j.issn.1008-8199.2007.11.019
2007-01-01
Abstract:Objective:To study the effects of Somatostatin-14 and-8 on portal hemodynamics and plasma levels of the insulin-like growth factor(IGF-1),nitric oxide(NO),endothelin-1(ET-1) and glucagon(GLU) in patients with portal hypertension after transjugular intrahepatic portosystemic shunt(TIPS). Methods:Fourteen portal hypertension patients underwent TIPS,their portal pressures directly measured by the intravenous catheter placed in the portal vein,the hemodynamic changes observed and the plasma levels of IGF-1,NO,ET-1 and GLU determined before and 8 and 24 hours after the infusion of Somatostatin-14 or-8 according to a cross-over design.Results:The average decrease in portal pressure after the intravenous infusion of Somatostatin-14 and-8 was(9.4±1.0) cmH2O and(5.0±1.0) cmH2O,respectively(P 0.01),with significant differences before and after the infusion as well as between the Somatostatin-14 and-8 groups(P 0.01).Significant reduction was observed in GLU and IGF-1(P0.05),but not in NO and ET-1(P0.05) 8 and 24 hours after the infusion.Conclusion:Both Somatostatin-14 and-8 can significantly reduce portal pressure,although the former is more potent than the latter.The underlying mechanism may involve their inhibition of the secretion of GLU,IGF-1 and other hormones as well as their reduction of hepatic metabolism and portal inflow.
What problem does this paper attempt to address?